Effects of zinc chloride on the hydrolysis of cyclic GMP and cyclic AMP by the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart
- PMID: 202321
- DOI: 10.1016/0005-2744(78)90331-5
Effects of zinc chloride on the hydrolysis of cyclic GMP and cyclic AMP by the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart
Abstract
In the presence of 10 micrometer Ca2+ and 5 mM Mg2+ (or 0.25 mM Mg2+), the addition of 100 micrometer Zn2+, Ni2+, Co2+, Fe2+, Cu2+ or 1 mM Mn2+ resulted in varying degrees of stimulation or inhibition of 10(-6) M cyclic GMP and cyclic AMP hydrolysis by the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart in the absence or presence of phosphodiesterase activator. The substrate specificity of the enzyme was altered under several conditions. The addition of Zn2+ in the presence of 5 mM Mg2+ and the absence of activator resulted in the stimulation of cyclic GMP hydrolysis over a narrow substrate range while reducing the V 65% due to a shift in the kinetics from non-linear with Mg2+ alone to linear in the presence of Zn2+ and Mg2+. Zn2+ inhibited the hydrolysis of cyclic GMP and cyclic AMP in the presence of activator with Ki values of 70 and 100 micrometer, respectively. Zn2+ inhibition was non-competitive with substrate, activator and Ca2+ but was competitive with Mg2+. In the presence of 10 micrometer Ca2+ and activator, a Ki of 15 micrometer for Zn2+ vs. Mg2+ was noted in the hydrolysis of 10(-6) M cyclic GMP. Several effects of Zn2+ are discussed which have been noted in other studies and might be due in part to changes in cyclic nucleotide levels following phosphodiesterase inhibition.
Similar articles
-
Properties of the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.Biochim Biophys Acta. 1977 Jan 11;480(1):194-203. doi: 10.1016/0005-2744(77)90333-3. Biochim Biophys Acta. 1977. PMID: 188479
-
Effects of CuCl2 on the hydrolysis of cyclic GMP and cyclic AMP by the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.Biochim Biophys Acta. 1978 Oct 18;543(3):273-82. doi: 10.1016/0304-4165(78)90045-4. Biochim Biophys Acta. 1978. PMID: 213129
-
Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.Biochim Biophys Acta. 1976 Apr 8;429(2):461-73. doi: 10.1016/0005-2744(76)90294-1. Biochim Biophys Acta. 1976. PMID: 177071
-
Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase.Adv Cyclic Nucleotide Res. 1975;5:195-211. Adv Cyclic Nucleotide Res. 1975. PMID: 165666 Review.
-
[Brain phosphodiesterase and its activator protein (author's transl)].Tanpakushitsu Kakusan Koso. 1977;22(6):625-31. Tanpakushitsu Kakusan Koso. 1977. PMID: 200977 Review. Japanese. No abstract available.
Cited by
-
Proteomic analysis shows the upregulation of erythrocyte dematin in zinc-restricted human subjects.Am J Clin Nutr. 2012 May;95(5):1096-102. doi: 10.3945/ajcn.111.032862. Epub 2012 Mar 28. Am J Clin Nutr. 2012. PMID: 22456662 Free PMC article.
-
The Critical Roles of Zinc: Beyond Impact on Myocardial Signaling.Korean J Physiol Pharmacol. 2015 Sep;19(5):389-99. doi: 10.4196/kjpp.2015.19.5.389. Epub 2015 Aug 20. Korean J Physiol Pharmacol. 2015. PMID: 26330751 Free PMC article. Review.
-
Specific inhibition of a calcium dependent activation of brain cyclic AMP phosphodiesterase activity by vinblastine.Experientia. 1979 Nov 15;35(11):1487-9. doi: 10.1007/BF01962801. Experientia. 1979. PMID: 228966
-
Copper complexes of non-steroidal antiinflammatory agents: analgesic activity and possible opioid receptor activation.Agents Actions. 1987 Jun;21(1-2):130-44. doi: 10.1007/BF01974933. Agents Actions. 1987. PMID: 2820213
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous